Contract Service Directory


Syngene





Company Headquarters

Syngene International Limited Biocon Park, SEZ, Plot No. 2 & 3,
Bommasandra Industrial Area – Phase-IV, Jigani Link Road
Bengaluru, KA 560 099
India

Contract Service Directory

    Content From Syngene

    Related Content

    • cGMP Manufacture | Drug Development | Promotions & Moves
      Syngene Adds Senior Leadership in the U.S.

      Syngene Adds Senior Leadership in the U.S.

      Alex Del Priore appointed Senior Vice President, Manufacturing Services, and Alan Collis appointed Vice President, Integrated Drug Discovery Services.
      08.06.21

    • Syngene International Ltd.

      Syngene International Ltd.

      Syngene is an integrated contract research, development and manufacturing organization providing scientific services from early discovery to commercial supply.
      07.26.21

    • Biologics, Proteins, Vaccines | Breaking News
      Dyadic Collaborates with Syngene to Develop Covid-19 Vaccine Candidate

      Dyadic Collaborates with Syngene to Develop Covid-19 Vaccine Candidate

      Will develop a candidate to immunize people against current and future variants.
      Charles Sternberg, Assistant Editor 05.26.21


    • Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Laboratory Testing
      Syngene, BMS Extend Long Term Research Alliance until 2030

      Syngene, BMS Extend Long Term Research Alliance until 2030

      Extension will include a 40% increase in the number of scientists and the addition of a new 50,000 sq.-ft. dedicated lab space.
      Kristin Brooks 04.28.21

    • Targeted Protein Degradation

      Targeted Protein Degradation

      Syngene has considerable experience solving synthetic chemistry and purification challenges with PROTACS.

    • Biologics and Manufacturing

      Biologics and Manufacturing

      Syngene offers Biologics development and Biomanufacturing solutions in both mammalian and microbial systems.


    • Your Pre-clinical Toxicology Program Needs a Strategy

      Your Pre-clinical Toxicology Program Needs a Strategy

      At Syngene, we have developed a roadmap across pre-IND, IND and NDA that seamlessly integrate the various pre-clinical studies.

    • Commercial Manufacturing

      Commercial Manufacturing

      Syngene supports manufacturing of regulatory starting materials, APIs, HPAPI, NCEs and novel advanced intermediates.

    • How Integrated CMC Can Help Expedite Early Phase Development of Small Molecules – A CRO Perspective

      How Integrated CMC Can Help Expedite Early Phase Development of Small Molecules – A CRO Perspective

      Syngene's 7-phase integrated CMC strategy helps expedite IND/IMPD filings and FIH studies.


    • Formulation Development

      Formulation Development

      Syngene supports both development and manufacturing of Drug Products from early to late stage.

    • Harnessing Targeted Protein Degradation

      Harnessing Targeted Protein Degradation

      Read how Syngene's partnership with a leading Biotech company working in the field of cancer therapy grew from one small pilot project to over 100 FTEs today.

    • ICH Stability Studies

      ICH Stability Studies

      One of the largest Stability facilities in Asia, Syngene supports both small and large molecules from early development to CMC filing and commercialization.


    • The Many Benefits of Outsourcing Stability: A Baxter-Syngene Case study

      The Many Benefits of Outsourcing Stability: A Baxter-Syngene Case study

      Learn why Baxter chose to partner with Syngene for Stability studies, the business flow, governance mechanism and metrics that were implemented.

    • Oligonucleotides

      Oligonucleotides

      Syngene's services encompass Therapeutic oligonucleotides, Diagnostic Oligonucleotides, Enzymatic synthesis and analytical services.

    • AAPS Exhibitor List

      ...
      10.29.19

    • Pricing Headwinds

      Pricing Headwinds

      Generic firms see red; CDMOs stay resilient
      S Harachand, Contributing Editor 07.17.19

    • GlaxoSmithKline

      GlaxoSmithKline

      ...
      07.15.19

    • Biologics, Proteins, Vaccines
      Ebullient Bio CMOs

      Ebullient Bio CMOs

      Firms see rich dividends from biosimilars
      S. Harachand, Contributing Editor 05.07.19

    • R&D
      Strategic Discovery

      Strategic Discovery

      CROs top offerings with biology skills.
      S. Harachand , Contributing Editor 10.10.18

    • HPAPI Outsourcing Likely to Gain Traction

      HPAPI Outsourcing Likely to Gain Traction

      A number of highly potent drugs will soon fall into the generic domain
      S. Harachand, Contributing Editor 09.11.18

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
      Artelo, Syngene Enter Partnership

      Artelo, Syngene Enter Partnership

      For the drug discovery and clinical development of ART27.13, Artelo's Phase 2 ready, high-potency dual cannabinoid agonist
      06.14.18

    • Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Syngene Signs R&D Agreement with GSK

      Syngene Signs R&D Agreement with GSK

      Syngene scientists to work with GSK to advance drug discovery in multiple therapeutic areas d
      03.27.18

    • Chemistry | Drug Discovery | Toxicology

      CROs Are Making Headlines

      India’s drug discovery service sector is heating up
      S. Harachand, Contributing Editor 09.11.15

    • Bioassay Development | Breaking News | Chemistry | Collaborations & Alliances | Drug Development | Drug Discovery | Methods Development | Process Development | Toxicology

      BMS, Syngene Expand Research Pact in India

      Will encompass a broader range of integrated service offerings
      06.03.14

    • APIs | Chemistry | Clinical Trials | Drug Development | Drug Discovery | Injectables | Process Development | R&D | Toxicology

      Discovering Partners

      R&D firms move from providing to partnering
      S. Harachand 01.17.08

    • Chemistry | Drug Discovery | R&D | Validation

      Bio-partnering: The New Mantra

      Alliance seekers turn India's biotech buoyant
      S. Harachand 04.03.07